First City Capital Management, Inc. Pfizer Inc Transaction History

First City Capital Management, Inc.

$194 Million
Q3 2024

A detailed history of First City Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First City Capital Management, Inc. holds 52,014 shares of PFE stock, worth $1.39 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

52,014

Previous 45,583 14.11%

Holding current value

$1.39 Million

Previous $1.28 Million 18.04%

% of portfolio

0.78%

Previous 0.73%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $178,138 - $201,869	6,431 Added 14.11%	52,014 $1.51 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $118,696 - $139,090	-4,699 Reduced 9.35%	45,583 $1.28 Million
Q1 2024 May 22, 2024	SELL	$25.89 - $29.73 $106,278 - $122,041	-4,105 Reduced 7.55%	50,282 $1.4 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $133,158 - $172,958	-5,096 Reduced 8.57%	54,387 $1.57 Million
Q3 2023 Oct 26, 2023	BUY	$32.09 - $37.51 $1,187 - $1,387	37 Added 0.06%	59,483 $1.97 Million
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $18,818 - $21,772	-521 Reduced 0.87%	59,446 $2.18 Million
Q1 2023 May 01, 2023	SELL	$39.39 - $51.28 $269,860 - $351,319	-6,851 Reduced 10.25%	59,967 $2.45 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $26,928 - $35,152	-645 Reduced 0.96%	66,818 $3.43 Million
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $37,589 - $45,887	-859 Reduced 1.26%	67,463 $2.95 Million
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $73,889 - $87,609	1,588 Added 2.38%	68,322 $3.58 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $32,574 - $40,363	-712 Reduced 1.06%	66,734 $3.46 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $53,302 - $79,012	1,290 Added 1.95%	67,446 $3.58 Million
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $88,312 - $113,445	2,250 Added 3.52%	66,156 $2.85 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $13,573 - $15,377	-378 Reduced 0.59%	63,906 $3.02 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $69,324 - $78,183	2,070 Added 3.33%	64,284 $2.55 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.7 Million - $2.16 Million	-50,680 Reduced 44.89%	62,214 $2.14 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $1.68 Million - $1.97 Million	52,863 Added 88.06%	112,894 $3.93 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $29,246 - $35,480	971 Added 1.64%	60,031 $1.96 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $27,813 - $39,739	-1,029 Reduced 1.71%	59,060 $1.93 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $921 - $1,046	-28 Reduced 0.05%	60,089 $2.35 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $74,727 - $96,899	-2,300 Reduced 3.68%	60,117 $2.16 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $2,773 - $3,114	-75 Reduced 0.12%	62,417 $2.7 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $103,762 - $114,000	-2,767 Reduced 4.24%	62,492 $2.65 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $868,267 - $989,920	-22,570 Reduced 25.7%	65,259 $2.85 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $23,887 - $28,974	-693 Reduced 0.78%	87,829 $3.87 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $2.92 Million - $3.11 Million	88,522 New	88,522 $3.21 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $2.84 Million - $3.29 Million	-88,971 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $63,260 - $67,121	-1,902 Reduced 2.09%	88,971 $3.22 Million
Q3 2017 Oct 31, 2017	SELL	$31.0 - $34.15 $32,457 - $35,755	-1,047 Reduced 1.14%	90,873 $3.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	91,920	91,920 $3.09 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Pfizer Inc Transaction History